Machine Learning Techniques and Drug Design

被引:126
|
作者
Gertrudes, J. C. [2 ]
Maltarollo, V. G. [3 ]
Silva, R. A. [2 ]
Oliveira, P. R. [2 ]
Honorio, K. M. [2 ,3 ]
da Silva, A. B. F. [1 ]
机构
[1] Univ Sao Paulo, Inst Quim Sao Carlos, Dept Quim & Fis Mol, BR-13560970 Sao Carlos, SP, Brazil
[2] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, BR-03828000 Sao Paulo, Brazil
[3] Univ Fed ABC, Ctr Ciencias Nat & Humanas, BR-09210170 Santo Andre, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Machine learning; drug design; QSAR; medicinal chemistry; ARTIFICIAL NEURAL-NETWORKS; SUPPORT VECTOR MACHINES; PARTIAL LEAST-SQUARES; SELF-ORGANIZING MAPS; QSAR MODELS; GENETIC ALGORITHM; IN-VITRO; ELECTROTOPOLOGICAL STATE; PROTEASE INHIBITORS; PREDICTION;
D O I
10.2174/092986712802884259
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The interest in the application of machine learning techniques (MLT) as drug design tools is growing in the last decades. The reason for this is related to the fact that the drug design is very complex and requires the use of hybrid techniques. A brief review of some MLT such as self-organizing maps, multilayer perceptron, bayesian neural networks, counter-propagation neural network and support vector machines is described in this paper. A comparison between the performance of the described methods and some classical statistical methods (such as partial least squares and multiple linear regression) shows that MLT have significant advantages. Nowadays, the number of studies in medicinal chemistry that employ these techniques has considerably increased, in particular the use of support vector machines. The state of the art and the future trends of MLT applications encompass the use of these techniques to construct more reliable QSAR models. The models obtained from MLT can be used in virtual screening studies as well as filters to develop/discovery new chemicals. An important challenge in the drug design field is the prediction of pharmacokinetic and toxicity properties, which can avoid failures in the clinical phases. Therefore, this review provides a critical point of view on the main MLT and shows their potential ability as a valuable tool in drug design.
引用
收藏
页码:4289 / 4297
页数:9
相关论文
共 50 条
  • [1] Advances in the application of machine learning techniques in drug discovery, design and development
    Barrett, S. J.
    Langdon, W. B.
    APPLICATIONS OF SOFT COMPUTING: RECENT TRENDS, 2006, : 99 - +
  • [2] DRUG DESIGN BY MACHINE LEARNING
    STERNBERG, MJE
    MUGGLETON, S
    SHRINIVASAN, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 165 - COMP
  • [3] DRUG DESIGN BY MACHINE LEARNING
    STERNBERG, MJE
    MUGGLETON, S
    SHRINIVASAN, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 138 - COMP
  • [4] Application of Machine Learning Techniques for Drug Discovery
    de Azevedo Jr, Walter Filgueira
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (38) : 7805 - 7807
  • [5] Survey of Machine Learning Techniques in Drug Discovery
    Stephenson, Natalie
    Shane, Emily
    Chase, Jessica
    Rowland, Jason
    Ries, David
    Justice, Nicola
    Zhang, Jie
    Chan, Leong
    Cao, Renzhi
    CURRENT DRUG METABOLISM, 2019, 20 (03) : 185 - 193
  • [6] Drug Design: The Machine Learning Roles
    EI-Telbany, Mohammed E.
    Rafat, Samah
    Nasr, Engy Ebrahim
    2014 INTERNATIONAL CONFERENCE ON ENGINEERING AND TECHNOLOGY (ICET), 2014,
  • [7] Machine Learning in Antibacterial Drug Design
    Jukic, Marko
    Bren, Urban
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [8] Application of machine learning in drug design
    King, RD
    STRUCTURE-BASED DRUG DESIGN: EXPERIMENTAL AND COMPUTATIONAL APPROACHES, 1998, 352 : 53 - 63
  • [9] LEARNING DESIGN CONCEPTS USING MACHINE LEARNING TECHNIQUES
    MAHER, ML
    LI, H
    AI EDAM-ARTIFICIAL INTELLIGENCE FOR ENGINEERING DESIGN ANALYSIS AND MANUFACTURING, 1994, 8 (02): : 95 - 111
  • [10] Application of machine learning techniques to chip design
    Sudhakaran, Sunil
    2024 IEEE WORKSHOP ON MICROELECTRONICS AND ELECTRON DEVICES, WMED, 2024, : XV - XV